Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 397

1.

Breast cancer screening using tomosynthesis in combination with digital mammography.

Friedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, Hayes MK, Copit DS, Carlson KL, Cink TM, Barke LD, Greer LN, Miller DP, Conant EF.

JAMA. 2014 Jun 25;311(24):2499-507. doi: 10.1001/jama.2014.6095.

PMID:
25058084
[PubMed - indexed for MEDLINE]
2.

Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography.

Kerlikowske K, Hubbard R, Tosteson AN.

J Natl Cancer Inst. 2014 Jul 16;106(8). pii: dju191. doi: 10.1093/jnci/dju191. Print 2014 Aug. No abstract available.

PMID:
25031310
[PubMed - indexed for MEDLINE]
3.

Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.

Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EA, Pabiniak C, van Ballegooijen M, Rutter CM, Kuntz KM, Feuer EJ, Etzioni R, de Koning HJ, Zauber AG, Mandelblatt JS.

Ann Intern Med. 2014 Jul 15;161(2):104-12. doi: 10.7326/M13-2867.

PMID:
25023249
[PubMed - indexed for MEDLINE]
4.

Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.

Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS.

J Natl Cancer Inst. 2014 May 28;106(6):dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun.

PMID:
24872543
[PubMed - indexed for MEDLINE]
5.

Mammographic density phenotypes and risk of breast cancer: a meta-analysis.

Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L, Vachon C, Bakker MF, Giles GG, Chia KS, Czene K, Eriksson L, Hall P, Hartman M, Warren RM, Hislop G, Chiarelli AM, Hopper JL, Krishnan K, Li J, Li Q, Pagano I, Rosner BA, Wong CS, Scott C, Stone J, Maskarinec G, Boyd NF, van Gils CH, Tamimi RM.

J Natl Cancer Inst. 2014 May 10;106(5). pii: dju078. doi: 10.1093/jnci/dju078. Review.

PMID:
24816206
[PubMed - indexed for MEDLINE]
6.

Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom.

Gunsoy NB, Garcia-Closas M, Moss SM.

Br J Cancer. 2014 May 13;110(10):2412-9. doi: 10.1038/bjc.2014.206. Epub 2014 Apr 24.

PMID:
24762956
[PubMed - indexed for MEDLINE]
7.

Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer.

Granados-Principal S, El-Azem N, Pamplona R, Ramirez-Tortosa C, Pulido-Moran M, Vera-Ramirez L, Quiles JL, Sanchez-Rovira P, Naudí A, Portero-Otin M, Perez-Lopez P, Ramirez-Tortosa M.

Biochem Pharmacol. 2014 Jul 1;90(1):25-33. doi: 10.1016/j.bcp.2014.04.001. Epub 2014 Apr 12.

PMID:
24727461
[PubMed - indexed for MEDLINE]
8.

Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy.

Koukourakis MI, Giatromanolaki A, Bottini A, Cappelletti MR, Zanotti L, Allevi G, Strina C, Ardine M, Milani M, Brugnoli G, Martinotti M, Ferrero G, Bertoni R, Ferrozzi F, Harris AL, Generali D.

Br J Cancer. 2014 Apr 29;110(9):2209-16. doi: 10.1038/bjc.2014.196. Epub 2014 Apr 10.

PMID:
24722179
[PubMed - indexed for MEDLINE]
9.

Long-term results of phase II ablation after breast lumpectomy added to extend intraoperative margins (ABLATE l) trial.

Klimberg VS, Ochoa D, Henry-Tillman R, Hardee M, Boneti C, Adkins LL, McCarthy M, Tummel E, Lee J, Malak S, Makhoul I, Korourian S.

J Am Coll Surg. 2014 Apr;218(4):741-9. doi: 10.1016/j.jamcollsurg.2013.12.032. Epub 2014 Jan 11.

PMID:
24655863
[PubMed - indexed for MEDLINE]
10.

Pseudocystic foveal cavitation in tamoxifen retinopathy.

Doshi RR, Fortun JA, Kim BT, Dubovy SR, Rosenfeld PJ.

Am J Ophthalmol. 2014 Jun;157(6):1291-1298.e3. doi: 10.1016/j.ajo.2014.02.046. Epub 2014 Feb 26.

PMID:
24582991
[PubMed - indexed for MEDLINE]
11.

Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk.

Sovio U, Li J, Aitken Z, Humphreys K, Czene K, Moss S, Hall P, McCormack V, dos-Santos-Silva I.

Br J Cancer. 2014 Apr 2;110(7):1908-16. doi: 10.1038/bjc.2014.82. Epub 2014 Feb 20.

PMID:
24556624
[PubMed - indexed for MEDLINE]
12.

Genetic variants improve breast cancer risk prediction on mammograms.

Liu J, Page D, Nassif H, Shavlik J, Peissig P, McCarty C, Onitilo AA, Burnside E.

AMIA Annu Symp Proc. 2013 Nov 16;2013:876-85. eCollection 2013.

PMID:
24551380
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Molecular imaging in the framework of personalized cancer medicine.

Belkić D, Belkić K.

Isr Med Assoc J. 2013 Nov;15(11):665-72.

PMID:
24511645
[PubMed - indexed for MEDLINE]
Free Article
14.

Quantitative ultrasound characterization of locally advanced breast cancer by estimation of its scatterer properties.

Tadayyon H, Sadeghi-Naini A, Wirtzfeld L, Wright FC, Czarnota G.

Med Phys. 2014 Jan;41(1):012903. doi: 10.1118/1.4852875.

PMID:
24387530
[PubMed - indexed for MEDLINE]
15.

BRCA1 deficiency induces protective autophagy to mitigate stress and provides a mechanism for BRCA1 haploinsufficiency in tumorigenesis.

Tang MK, Kwong A, Tam KF, Cheung AN, Ngan HY, Xia W, Wong AS.

Cancer Lett. 2014 Apr 28;346(1):139-47. doi: 10.1016/j.canlet.2013.12.026. Epub 2013 Dec 28.

PMID:
24378767
[PubMed - indexed for MEDLINE]
16.

In vivo proton-electron double-resonance imaging of extracellular tumor pH using an advanced nitroxide probe.

Samouilov A, Efimova OV, Bobko AA, Sun Z, Petryakov S, Eubank TD, Trofimov DG, Kirilyuk IA, Grigor'ev IA, Takahashi W, Zweier JL, Khramtsov VV.

Anal Chem. 2014 Jan 21;86(2):1045-52. doi: 10.1021/ac402230h. Epub 2014 Jan 6.

PMID:
24372284
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme.

Dibden A, Offman J, Parmar D, Jenkins J, Slater J, Binysh K, McSorley J, Scorfield S, Cumming P, Liao XH, Ryan M, Harker D, Stevens G, Rogers N, Blanks R, Sellars S, Patnick J, Duffy SW.

Br J Cancer. 2014 Feb 4;110(3):560-4. doi: 10.1038/bjc.2013.778. Epub 2013 Dec 24.

PMID:
24366303
[PubMed - indexed for MEDLINE]
18.

Bone mineral density and the risk of breast cancer: a case-control study of Korean women.

Kim BK, Choi YH, Song YM, Park JH, Noh HM, Nguyen TL, Hopper JL.

Ann Epidemiol. 2014 Mar;24(3):222-7. doi: 10.1016/j.annepidem.2013.11.009. Epub 2013 Nov 26.

PMID:
24360852
[PubMed - indexed for MEDLINE]
19.

Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy.

Cai D, Gao W, He B, Dai W, Zhang H, Wang X, Wang J, Zhang X, Zhang Q.

Biomaterials. 2014 Feb;35(7):2283-94. doi: 10.1016/j.biomaterials.2013.11.088. Epub 2013 Dec 19.

PMID:
24360410
[PubMed - indexed for MEDLINE]
20.

Anticoagulant medication at time of needle biopsy for breast cancer in relation to risk of lymph node metastasis.

Ljung R, Sennerstam R, Mattsson F, Auer G, Lagergren J.

Int J Cancer. 2014 Jul 1;135(1):238-41. doi: 10.1002/ijc.28671. Epub 2013 Dec 31.

PMID:
24346771
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk